| Entry |
|
|---|
| Name |
Dipyridamole (JP18/USP/INN);
Persantine (TN) |
|---|
| Product |
|
|---|
| Generic |
DIPYRIDAMOLE (ANI Pharmaceuticals), DIPYRIDAMOLE (Golden State Medical Supply), DIPYRIDAMOLE (HF Acquisition Co LLC), DIPYRIDAMOLE (Henry Schein), DIPYRIDAMOLE (Hikma Pharmaceuticals USA), DIPYRIDAMOLE (Lannett Company), DIPYRIDAMOLE (Oxford Pharmaceuticals), DIPYRIDAMOLE (Proficient Rx LP), DIPYRIDAMOLE (Rising Pharmaceuticals), DIPYRIDAMOLE (Zydus Lifesciences Limited), DIPYRIDAMOLE (Zydus Pharmaceuticals USA) |
|---|
| Formula |
C24H40N8O4
|
|---|
| Exact mass |
504.3173
|
|---|
| Mol weight |
504.6256
|
|---|
| Structure |
|
|---|
| Class |
Cardiovascular agent
DG01509 Phosphodiesterase V inhibitor
Blood modifier agent
DG01950 Antithrombotic agent
DG01712 Antiplatelet agent
|
|---|
| Remark |
| Therapeutic category: | 2171 |
| Product (mixture): | D11615<US> |
|
|---|
| Efficacy |
Vasodilator (coronary), Platelet aggregation inhibitor, Phosphodiesterase inhibitor |
|---|
| Comment |
Pyrimido-pyrimidine derivative
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
B BLOOD AND BLOOD FORMING ORGANS
B01 ANTITHROMBOTIC AGENTS
B01A ANTITHROMBOTIC AGENTS
B01AC Platelet aggregation inhibitors excl. heparin
B01AC07 Dipyridamole
D00302 Dipyridamole (JP18/USP/INN) <JP/US>
USP drug classification [BR:br08302]
Blood Products and Modifiers
Platelet Modifying Agents
Platelet Modifying Agents, Other
Dipyridamole
D00302 Dipyridamole (JP18/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
21 Cardiovascular agents
217 Vasodilators
2171 Coronary dilators
D00302 Dipyridamole (JP18/USP/INN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01509 Phosphodiesterase V inhibitor
D00302 Dipyridamole
Blood modifier agent
DG01950 Antithrombotic agent
DG01712 Antiplatelet agent
D00302 Dipyridamole
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Phosphodiesterases
PDE4A
D00302 Dipyridamole (JP18/USP/INN) <JP/US>
PDE5
D00302 Dipyridamole (JP18/USP/INN) <JP/US>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00302 Dipyridamole
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 36
1 C8y C 21.7700 -17.7144
2 C8y C 21.7700 -16.3056
3 C8y C 20.5532 -18.4130
4 N5x N 22.9868 -18.4130
5 C8y C 22.9868 -15.6127
6 N5x N 20.5532 -15.6127
7 N1y N 20.5532 -19.8103
8 N5x N 19.3423 -17.7144
9 C8y C 24.1919 -17.7144
10 N1y N 22.9868 -14.2097
11 N5x N 24.1919 -16.3056
12 C8y C 19.3423 -16.3056
13 C1x C 19.3423 -20.5089
14 C1x C 21.7700 -20.5089
15 N1c N 25.4087 -18.4073
16 C1x C 24.2036 -13.5111
17 C1x C 21.7757 -13.5052
18 N1c N 18.1313 -15.6127
19 C1x C 19.3423 -21.9121
20 C1x C 21.7700 -21.9121
21 C1b C 25.4087 -19.8103
22 C1b C 26.6139 -17.7086
23 C1x C 24.2036 -12.1079
24 C1x C 21.7757 -12.1079
25 C1b C 18.1313 -14.2097
26 C1b C 16.9204 -16.3056
27 C1x C 20.5532 -22.6048
28 C1b C 26.6139 -20.5148
29 C1b C 27.8306 -18.4073
30 C1x C 22.9925 -11.4152
31 C1b C 16.9204 -13.5052
32 C1b C 15.7094 -15.6127
33 O1a O 27.8306 -19.8103
34 O1a O 29.0415 -17.7027
35 O1a O 15.7094 -14.2097
36 O1a O 14.4985 -16.3056
BOND 39
1 1 2 2
2 1 3 1
3 1 4 1
4 2 5 1
5 2 6 1
6 3 7 1
7 3 8 2
8 4 9 2
9 5 10 1
10 5 11 2
11 6 12 2
12 7 13 1
13 7 14 1
14 9 15 1
15 10 16 1
16 10 17 1
17 12 18 1
18 13 19 1
19 14 20 1
20 15 21 1
21 15 22 1
22 16 23 1
23 17 24 1
24 18 25 1
25 18 26 1
26 19 27 1
27 21 28 1
28 22 29 1
29 23 30 1
30 25 31 1
31 26 32 1
32 28 33 1
33 29 34 1
34 31 35 1
35 32 36 1
36 8 12 1
37 9 11 1
38 20 27 1
39 24 30 1
|
|---|
